Compugen Stock

Compugen Equity Ratio

The Equity Ratio of Compugen (CGEN) as of Sep 14, 2026 is 65.49 %. In the previous year, Equity Ratio was 47.75 % — a change of 37.14% (higher).

Equity Ratio

65.49 %

YoY

37.14%

Last updated:

Equity Ratio of Compugen is 2026 65.49 % . Equity Ratio of Compugen was 2025 47.75 % . It decreases by 37.14% higher compared to the previous year.

The Compugen Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
70.03 USD
Jan 1, 2019
71.28 USD
Jan 1, 2020
86.60 USD
Jan 1, 2021
80.73 USD
Jan 1, 2022
82.48 USD
Jan 1, 2023
54.03 USD
Jan 1, 2024
47.75 USD
Jan 1, 2025
65.49 USD
The Compugen Equity Ratio history
YEAREquity RatioYoY
65.49 %+37.14%
47.75 %-11.62%
54.03 %-34.49%
82.48 %+2.17%
80.73 %-6.78%
86.60 %+21.50%
71.28 %+1.78%
70.03 %-7.38%
75.61 %-15.32%
89.29 %-1.37%
90.52 %-1.90%
92.28 %
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Equity Ratio of Compugen is 65.49 % in 2026.

Equity Ratio of Compugen changed from 47.75 % to 65.49 %, representing a 37.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Compugen

All Key Metrics — Compugen